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Introduction: Cobalamin/Vitamin B12 (Cbl) is an essential vitamin, supplied mainly as hydroxocobalamin
(OHCbl) by animal products, including cows' milk. Cyanocobalamin (CNCbl) is the usual form in vitamin
pills. The aim was to explore absorption and tissue accumulation of two Cbl forms, administered alone or
bound to milk protein.
Materials and methods: We synthesized labeled OH[57Co]Cbl from commercially available CN[57Co]Cbl.
Recombinant bovine transcobalamin (rbTC) was produced in yeast and skimmed milk obtained off the
shelf. Male Wistar rats (250e300 g) received labeled Cbl by gastric gavage. First, we administered CN
[57Co]Cbl, free or rbTC-bound (n ¼ 15 in each group). Rats were sacriﬁced after two, 24, and 48 h. In the
following studies, rats were sacriﬁced after 24 h. We compared absorption of free or rbTC-bound CN
[57Co]Cbl added to cows' milk and analogous absorption of OH[57Co]Cbl, free or rbTC-bound, to ab-
sorption of free CN[57Co]Cbl, (n ¼ 10 in each group). Blood, tissues, 24-h urine and feces were collected.
Labeled Cbl was measured using a gamma counter. Results are expressed as percentage of administered
dose.
Results: Absorptions of CNCbl and OHCbl were neither inﬂuenced by rbTC-binding nor administration in
milk. Absorption increased in the ﬁrst 24 h with no further tissue accumulation during the subsequent
24 h. Accumulation of free CNCbl and (OHCbl) was 1.4, (4.1) (liver); 20.2, (16.4) (kidney); and 0.05, (0.02)
(plasma)% 24 h after administration. Total organ accumulations were 21.6, (20.5)%. While total accu-
mulations of CNCbl and OHCbl were equal, distributions between liver, kidney, and plasma showed
signiﬁcant differences (p < 0.0001; p ¼ 0.01; p < 0.0001).
Conclusions: Cbl added to milk (spiked with rbTC) has high bioavailability matching that of free Cbl.
OHCbl and CNCbl are absorbed equally well, but much more OHCbl accumulated in the liver. Beneﬁts of
oral supplementation with OHCbl compared to CNCbl should be investigated.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cobalamin (Cbl) or vitamin B12 is a water-soluble vitamin
naturally present in foods of animal origin and also available as a
synthetic dietary supplement or as a prescription drug. Cbl is
essential for proper red blood cell formation, normal neurological
function, and DNA synthesis [1]. In animal products, Cbl isl, hydroxo-Cbl; CNCbl, cyano-
ovine transcobalamin; rbTC,
.
chemistry, Aarhus University
B.V. This is an open access article upredominantly protein-bound [2,3]. The vitamin is released by
hydrochloric acid, gastric pepsin, and pancreatic enzymes in the
upper gastrointestinal tract. Subsequently, gastric-derived intrinsic
factor binds Cbl and facilitates receptor-mediated Cbl absorption in
the distal ileum [4]. Synthetic Cbl in fortiﬁed foods and dietary
supplements is present in free form. Natural Cbl exists as hydroxo-/
aquo-Cbl (OHCbl) and two coenzyme forms (methyl-Cbl and 5’-
deoxyadenosyl-Cbl). All of these forms are present in food, but
coenzymes are light sensitive and, therefore, easily degraded to
OHCbl upon light exposure [5,6]. In contrast, most vitamin pills
contain cyano-Cbl (CNCbl). The scarce studies comparing absorp-
tion of CNCbl and OHCbl do not address efﬁcacy of the two vitamin
forms. Synthetic CNCbl is considered to be superior to OHCbl in oral
supplementation, since synthetic OHCbl may be vulnerable to thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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of food-bound Cbl is less efﬁcient (compared to free Cbl) due to
incomplete food matrix digestion and hampered vitamin release
from food proteins. However, recent studies suggest that milk-
bound Cbl may be a better Cbl source than the free CNCbl [8e11].
In cows' milk, Cbl occurs mainly as OHCbl [5], and the main Cbl-
binding protein is transcobalamin (bTC) [12]. TC is also known to
bind Cbl in plasma, facilitating cellular vitamin uptake by receptor-
mediated endocytosis [4].
Cbl absorption in rats resembles that in humans. As in humans,
Cbl is liberated from food proteins by action of gastric acid, pepsin
and pancreatic enzymes. Intestinal absorption in rats is IF-
mediated, and receptor binding sites are situated in the ileum
[13e15].
This study aims to explore intestinal absorption and tissue
accumulation of a single oral dose of CNCbl or OHCbl in rats. The
cobalamins are administered as free vitamins or bound to recom-
binant bTC (rbTC) diluted with water or bovine milk.
2. Materials and methods
2.1. Animals
Male Wistar rats (Taconic Bioscience Inc.) were used for the
experiments (approx. 200 g at arrival to our animal facilities). Rats
were housed in pairs in standard cages and fed standard mainte-
nance diet (Altromin 1324, Brogaarden, Denmark) containing
0.024 mg Cbl per kg. We allowed rats to acclimatize for two weeks
in the animal facilities before starting the experiments.
All experiments were conducted in agreement with the EU
Directive 2010/63/EU for animal experiments.
2.2. Reagents and biochemical methods
2.2.1. CN[57Co]Cbl
Commercially available preparations of CN[57Co]Cbl (MP Bio-
medicals, Ohio, USA, Catalogue no. 06B-430000),1.75 mCi/mL and
0.41 mCi/pmol Cbl were used.
2.2.2. OH[57Co]Cbl
Labeled CN[57Co]Cbl was converted to OH[57Co]Cbl by photo-
aquation in acidic medium under nitrogen bubbling (for theoretical
background see Ref. [16]). Initially, CN[57Co]Cbl was extracted with
one volume (v) of phenol-chloroform (1:1 equilibrated with 0.1 M
Tris pH 7.5) to remove salts of the original solvent. The organic
phase at the bottomwas collected and washed with two volumes of
water. One volume of chloroform, one volume of acetone and one
volume of water were added to the sample. The suspension was
vigorously shaken and the upper aqueous phase containing CN
[57Co]Cbl collected after a brief centrifugation (30 s, 10,000 g). The
aqueous phase was shaken with two volumes of diethyl ether to
remove rest of phenol and the upper organic phase discarded.
Radioactivity loss after all extractions was below 5%. The aqueous
solution of puriﬁed CN[57Co]Cbl was acidiﬁed by HCl (ﬁnal con-
centration of 3 mM). The sample was placed into an open glass tube
at a distance of approximately 15 cm from a light bulb (40 W).
Gentle nitrogen bubbling through the solution was continued over
20 h. The sample was neutralized by adding phosphate buffer, pH 6
(ﬁnal concentration of 10 mM) and 3 mM NaOH. The solution was
extracted by phenol-chloroform and water as described above,
whereupon the salt-free sample (1 v) was applied to a CM
Sepharose column (0.5 v, prewashed with 0.1 MHCl,1 M phosphate
buffer pH 6 and equilibrated with water). The column bound OH
[57Co]Cbl (positively charged at pH 6), whereas all other cobalamins
were washed out with two e three v of water. Finally, OH[57Co]Cblwas eluted with 0.15 M NaCl. Total yield corresponded to 80% of the
original radioactivity. Content of OH[57Co]Cbl in the prepared
sample was estimated as above 98% using HPLC method described
in Ref. [17].
2.2.3. Recombinant bovine transcobalamin
Recombinant bovine transcobalamin (rbTC) was expressed and
puriﬁed essentially as previously described ([18,19]). In brief, we
employed Pichia pastoris (SMD 1168) transformed with a pPICZ
expression vector (with removed sequences of c-Myc and His6
tags) carrying cDNA of bTC. The Cbl-saturated rbTC was puriﬁed by
ammonium sulfate precipitation followed by batch puriﬁcation on
CM sepharose and gel ﬁltration on a Sephacryl S-200 column. Un-
saturated apo-rbTC was prepared by dialyzing the puriﬁed holo-
rbTC (1 mg/mL) (12e14 kDa cut-off) against excess of 5 M guani-
dine hydrochloride (30 C for 96 h) with changes after 48 and 72 h,
followed by 48 h dialysis against excess of phosphate buffer (10mM
sodium phosphate, 150 mM NaCl, pH 7.4). The ﬁnal product was
stored at 20 C.
2.2.4. Milk
Organic skimmed milk (Arla Foods) was purchased at a local
supermarket.
2.2.5. Unlabeled CNCbl
Commercially available cyanocobalamin (SigmaeAldrich),
218 pmol/mL was used.
2.2.6. Unsaturated Cbl binding capacity
Cbl content in milk was measured employing the routine
method available on Cobas 6000 (Roche). Unsaturated binding ca-
pacity of rbTC was measured by adding labeled Cbl tracer (25 mL CN
[57Co]Cbl) to the solution. After 15 min incubation, excess free
tracer was removed with Cbl-binding haptocorrin-coated magnetic
beads (method described in Ref. [20]). Remaining tracer bound to
rbTC was measured by gamma counting (Perkin Elmer/Wallac
Wizard-2 2470 Automatic Gamma Counter).
2.2.7. Solutions for gastric gavage
Free and protein bound X[57Co]Cbl (X¼ CN or OH) was prepared
on the experimental day. Labeled Cbl was adjusted to the desired
Cbl concentration by adding unlabeled Cbl. Protein-bound Cbl was
prepared by incubating labeled Cbl with an excess of rbTC binding
capacity (þ10%) for 1 h at room temperature. Subsequently, labeled
Cbl, free or bound to rbTC, was diluted as described in 1.4 allowing
administration of 100,000e150,000 cpm to each rat. The exact
amount of administered Cbl (in cpm) was calculated based on
counts of cpm in 1 mL of solution measured by gamma counting.
3. Study design
3.1. Absorption of free CNCbl compared to rbTC-bound CNCbl
Two groups of rats (each n ¼ 15) received app. 100,000 cpm
(adjusted to 0.50 pmol Cbl) as free CNCbl or CNCbl in complex with
rbTC. Solutions were diluted with 0.4 mL demineralized water and
administered by gastric gavage. Five rats from each group were
placed in individual metabolic cages for two and 24 h. The
remaining ﬁve rats from each group were kept in pairs in standard
cages for the initial 24 h and in individual metabolic cages between
24 and 48 h. Five rats from each group were sacriﬁced by cervical
dislocation at two, 24, and 48 h following administration. Small
intestine, kidneys, and liver were collected and frozen on dry ice.
Radioactivity accumulation inwhole organs and small intestinal
contents was determined.
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skimmed milk compared to free CNCbl
Three groups of rats (each n ¼ 10) received 150,000 cpm CNCbl,
free or bound to rbTC diluted with demineralized water or organic
skimmed milk. Cbl concentration in skimmed milk was 2372 pmol/
L with a resulting contribution of 1.2 pmol unlabeled milk Cbl per
rat. To make sure that all rats received the same total Cbl amount,
unlabeled Cbl was added to the solution of free CN[57Co]Cbl in
demineralized water. Total administered volume and CNCbl
amount per rat was 0.5 mL and 1.42 pmol. Solutions were admin-
istered by gastric gavage.
Rats were kept in pairs in standard cages throughout the
experiment and sacriﬁced after 24 h by cervical dislocation, kidneys
and liver were collected for radioactivity determination as
described in 3.1.
3.3. Absorption of OHCbl (free or bound to rbTC) compared to free
CNCbl
Three groups of rats (each n ¼ 10) received 150,000 cpm CN- or
OH[57Co]Cbl (0.21 pmol) as free vitamin or OH[57Co]Cbl in complex
with rbTC (see above). Cbls were dilutedwith 0.15MNaCl, and 1mL
was administered to each rat by gastric gavage. NaCl was used as
solvent to stabilize OHCbl by providing ionic strength to the solu-
tion. Rats were kept in standard cages throughout the experiment
and sacriﬁced after 24 h as described in 3.1.
Blood was collected by cardiac puncture into lithium-heparin
tubes and centrifuged at 1850 g for 9 min. Plasma was stored
at 80 until further analysis. Kidney and liver were collected for
radioactivity determination as described in 3.1.
4. Statistical analysis
Statistical analyses were performed using GraphPad Prism for
Mac OS X, Version 6.0 e and Stata/IC 13.1 for Mac. Mean organ
radioactivity is displayed as percent of cpm of the total adminis-
tered dose per rat. One-way ANOVA or KruskaleWallis test were
employed when appropriate in comparing means between three
groups; two-tailed t-test or ManneWhitney's test in comparing
means between two groups. Tests were considered statistically
signiﬁcant when p-values were <0.05 (2-sided tests).
5. Results
5.1. Basic rat characteristics
All rats weighed approximately 200 g at arrival to the animal
facilities and 260e319 g at the experimental day. No signiﬁcant
differences in body or organweight were detected between groups
in the experiments.
5.2. Absorption of free CNCbl compared to rbTC-bound CNCbl
Absorption of free CNCbl and rbTC-bound CNCbl was compa-
rable. After 2 h, the majority of the administered dose accumulated
in the intestinal contents. Only 3% was found in the intestinal wall
and <1% in liver and kidneys. Mean 24-h accumulation of CNCbl vs.
rbTC-CNCbl was 1.1, 1.3% (liver); 13.5, 16.5% (kidney), and 22.9,
24.3% (all NS). No major changes were found after 48 h (Fig. 1).
5.3. Absorption of CNCbl (free or bound to rbTC) in skimmed milk
compared to free CNCbl
Absorption and 24-h tissue accumulation of free CNCblcompared to free and rbTC-bound CNCbl in skimmed milk was
studied. The results were not affected when substituting the
demineralized water for skimmed milk. Mean accumulation of
CNCbl in milk, rbTC-CNCbl in milk, and free CNCbl was 2.0, 1.8, 2.1%
(liver) and 18.3, 18.8, 21.0% (both NS) (Fig. 2).
5.4. Absorption of OHCbl (free or bound to rbTC) compared to free
CNCbl
Finally, liver and kidney absorption levels of free OHCbl and
rbTC-bound OHCbl were compared to free CNCbl, all diluted with
saline (Fig. 3). No signiﬁcant differences in absorption were
observed between free or protein-bound OHCbl. Total amount of
accumulated Cbl amount (found in liver and kidney taken together)
was comparable for all administered Cbl forms (Fig. 3). However,
noticeable distributional differences were observed between free
forms of OHCbl and CNCbl. Mean accumulation of free CNCbl and
(OHCbl) was 1, (4)% (liver); 20, (16)% (kidney); and 0.05, (0.02)%
(plasma) (p < 0.0001, 0.01 and <0.001).
6. Discussion
We explored oral absorption of CNCbl and OHCbl in free forms
or bound to recombinant bovine transcobalamin (the Cbl carrier in
cows' milk). Additionally, we explored absorption of Cbl diluted
with cows' milk. Our study demonstrates three important ﬁndings.
First, total Cbl accumulation in liver and kidney taken together is
practically equal, whether Cbl is administered as OHCbl or CNCbl.
Second, tissue distribution of absorbed OHCbl differs from that of
CNCbl. Third, Cbl is absorbed similarly if supplied in free form,
bound to a milk-derived binding protein, or diluted with cows'
milk.
We show that a total amount of approximately 20% of the
administered dose of Cbl is present in the examined rat organs after
24 h, which agrees with results obtained after parenteral admin-
istration of either CNCbl or OHCbl [21e23]. While OHCbl is rec-
ommended for parenteral treatment of Cbl deﬁciency, CNCbl is
preferred for oral treatment [13,14]. This choice is explained by
structural differences, considered to render OHCbl more vulnerable
to extreme pH and reducing agents than CNCbl because of the
exposed nature of its cobalt ion, unprotected by the strong CN-
group [7]. Based on this fact, OHCbl is considered less stable than
CNCbl in the GI tract. Yet, our data show comparable absorptions of
the two forms of Cbl, thereby questioning the beneﬁts of using
CNCbl for oral treatment instead of OHCbl.
Rats express only one circulating Cbl-binding protein, TC [24],
and both Cbl forms bind to this protein with comparable afﬁnities
[7]. TC transports Cbl into the cells via the membrane receptor
CD320 [25]. Surprisingly, we observed signiﬁcantly different dis-
tributions of OHCbl and CNCbl in the main accumulating tissues.
Compared to CNCbl, OHCbl accumulation was much higher in liver
but lower in kidney, the Cbl storage organ in rats [26e28]. Yet, it
should be kept in mind that Cbl supplies to these two organs differ
in their routes. Cbl reaches the liver via portal vein and hepatic
artery supplies, whereas kidney Cbl originates from both renal ar-
tery supply and megalin-mediated reuptake in proximal tubules
[29]. Currently, we suggest two feasible explanations for the higher
liver OHCbl accumulation. 1) We hypothesize that liver receptors
may recognize TC bound to OHCbl better than TC bound to CNCbl.
This possibility has been conjectured earlier [19]. The structures of
the two holo-proteins differ slightly because His-residues of TC is
coordinated to OHCbl, but not to CNCbl [19,30]. In addition,
recognition of TC by liver receptors does not always predict efﬁcient
cellular internalization of different Cbl forms [31]. 2) The second e
and totally speculative explanatione implies a faster cellular exit of
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Fig. 1. Radioactivity accumulation in rat liver, kidney, small intestinal wall, intestinal contents, feces and total accumulation in liver, kidney, and small intestinal wall at two, 24, and
48 h after an oral dose of CNCbl (CN, C) and rbTC-CNCbl (rbTC, B). No signiﬁcant differences were observed between free CNCbl and CNCbl bound to recombinant bovine
transcobalamin (rbTC).
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reduction [16] necessary to produce the coenzymes. Accelerated
conversion of OHCbl may help en retention of the derived X[57Co]
Cbl within the cell.
To the best of our knowledge, the present study is the ﬁrst one,
where oral uptakes of OHCbl and CNCbl are aligned. Our results are
partly supported by older studies on parenterally administered Cbl
in both rat and man. Uchino et al. found rat liver accumulation of
13% vs. 7.8% when administered as OHCbl vs. CNCbl 24 h after i.v.
injection [23]. Boddy and colleagues found a two-fold higher
whole-body radioactivity retained in humans three days after
intramuscular injection of labeled OHCbl compared to CNCbl [32].
Similar results have been reported by others in both healthy in-
dividuals and patients with pernicious anemia or end stage renal
disease [33e36].
Our results, together with earlier studies on parenterally
administered Cbl, demonstrate that OHCbl is absorbed and retained
at least as efﬁciently as CNCbl. Moreover, a signiﬁcantly higher liver
accumulation of OHCbl (or OHCbl-derived cofactor forms)compared to CNCbl may be of utmost metabolic importance.
We also studied absorption of labeled CNCbl in skimmedmilk as
free vitamin or bound to milk-derived bovine transcobalamin. Our
results clearly demonstrate that milk and bovine transcobalamin
have no effect on Cbl absorption. Previous studies reported high
bioavailability of milk Cbl [8e11]. Matte et al. even report slightly
higher absorption of milk Cbl compared to free Cbl in an in vivo pig
model [8]. Such results seemwell explained in the light of our data.
Milk primarily contains OHCbl [5]. In our study, OHCbl and CNCbl
absorption was compared. Hence, our results could simply reﬂect
that tissue accumulation of OHCbl is better than that of CNCbl.
In conclusion, we show that free OHCbl, the prevailing Cbl form
present in food items, is absorbed as efﬁciently as free CNCbl, and
that OHCbl is retained in liver far more efﬁciently than CNCbl. Our
data suggest that efﬁcacy of oral OHCbl administration matches or
exceeds that of oral CNCbl administration, and Cbl bound to milk
proteins is absorbed as efﬁciently as free Cbl.
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recombinant bovine transcobalamin (rbTC-CNCbl) (▫) in milk. No signiﬁcant differences were observed between the various CNCbl forms.
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